US Stock MarketDetailed Quotes

SGMT Sagimet Biosciences

Watchlist
  • 5.540
  • +0.370+7.16%
Close Nov 27 16:00 ET
  • 5.790
  • +0.250+4.51%
Post 20:01 ET
178.36MMarket Cap-4755P/E (TTM)

Sagimet Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
49.73%152.49M
798.92%166.37M
667.03%193.71M
193.39%94.9M
193.39%94.9M
--101.84M
--18.51M
--25.25M
-42.99%32.35M
--32.35M
-Cash and cash equivalents
-24.38%77.01M
418.47%95.96M
1,332.78%176.78M
47,456.33%75.14M
47,456.33%75.14M
--101.84M
--18.51M
--12.34M
-99.72%158K
--158K
-Short-term investments
--75.47M
--70.41M
31.06%16.93M
-38.61%19.76M
-38.61%19.76M
--0
--0
--12.92M
--32.19M
--32.19M
Prepaid assets
379.04%4.3M
143.14%248K
79.37%678K
227.36%1.35M
227.36%1.35M
--897K
--102K
--378K
-2.36%413K
--413K
Current deferred assets
--306K
--0
--0
--323K
--323K
----
--2.64M
--1.33M
--0
--0
Other current assets
31.17%101K
21.50%130K
30.12%108K
117.65%74K
117.65%74K
--77K
--107K
--83K
-59.52%34K
--34K
Total current assets
52.88%157.19M
680.89%166.75M
619.06%194.49M
194.72%96.65M
194.72%96.65M
--102.82M
--21.35M
--27.05M
-44.10%32.79M
--32.79M
Non current assets
Net PPE
4.59%114K
4.86%151K
-79.21%37K
-65.57%73K
-65.57%73K
--109K
--144K
--178K
-38.01%212K
--212K
-Gross PPE
4.59%114K
4.86%151K
-79.21%37K
-65.57%73K
-65.57%73K
--109K
--144K
--178K
-38.01%212K
--212K
Investments and advances
--17.47M
--22.12M
----
----
----
----
----
----
----
----
Non current prepaid assets
----
----
----
--0
--0
--0
--0
--27K
0.00%27K
--27K
Total non current assets
16,033.03%17.59M
15,364.58%22.27M
-81.95%37K
-69.46%73K
-69.46%73K
--109K
--144K
--205K
-35.23%239K
--239K
Total assets
69.81%174.78M
779.24%189.02M
613.79%194.53M
192.81%96.72M
192.81%96.72M
--102.93M
--21.5M
--27.25M
-44.05%33.03M
--33.03M
Liabilities
Current liabilities
Payables
-32.31%1.15M
-26.77%1.99M
-63.66%531K
-83.47%186K
-83.47%186K
--1.7M
--2.72M
--1.46M
47.83%1.13M
--1.13M
-accounts payable
-32.31%1.15M
-26.77%1.99M
-63.66%531K
-83.47%186K
-83.47%186K
--1.7M
--2.72M
--1.46M
47.83%1.13M
--1.13M
Current accrued expenses
-10.67%2.81M
53.86%3.57M
12.24%3.95M
30.42%5.17M
30.42%5.17M
--3.15M
--2.32M
--3.52M
189.34%3.96M
--3.96M
Current debt and capital lease obligation
12.62%116K
9.29%153K
-81.02%26K
-51.13%65K
-51.13%65K
--103K
--140K
--137K
7.26%133K
--133K
-Current capital lease obligation
12.62%116K
9.29%153K
-81.02%26K
-51.13%65K
-51.13%65K
--103K
--140K
--137K
7.26%133K
--133K
Other current liabilities
-88.42%11K
-90.29%10K
----
308.77%233K
308.77%233K
--95K
--103K
--167K
-69.19%57K
--57K
Current liabilities
-18.95%4.09M
8.34%5.73M
-14.70%4.51M
7.10%5.65M
7.10%5.65M
--5.05M
--5.29M
--5.29M
116.35%5.28M
--5.28M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
--0
--0
--0
--0
--39K
-65.18%78K
--78K
-Long term capital lease obligation
----
----
----
--0
--0
--0
--0
--39K
-65.18%78K
--78K
Derivative product liabilities
----
----
----
--0
--0
--1K
----
----
--4K
--4K
Preferred securities outside stock equity
----
----
----
--0
--0
--0
--214.63M
--214.63M
-0.00%214.62M
--214.62M
Total non current liabilities
--0
--0
--0
--0
--0
--1K
--214.63M
--214.67M
-0.07%214.7M
--214.7M
Total liabilities
-18.97%4.09M
-97.40%5.73M
-97.95%4.51M
-97.43%5.65M
-97.43%5.65M
--5.05M
--219.91M
--219.95M
1.24%219.98M
--219.98M
Shareholders'equity
Share capital
50.00%3K
200.00%3K
200.00%3K
100.00%2K
100.00%2K
--2K
--1K
--1K
0.00%1K
--1K
-common stock
50.00%3K
200.00%3K
200.00%3K
100.00%2K
100.00%2K
--2K
--1K
--1K
0.00%1K
--1K
-Preferred stock
--0
--0
--0
--0
--0
--0
----
----
--0
--0
Retained earnings
-15.53%-279.11M
-12.43%-264.49M
-12.22%-256.37M
-12.56%-249.74M
-12.56%-249.74M
---241.59M
---235.24M
---228.46M
-15.94%-221.87M
---221.87M
Paid-in capital
32.37%449.35M
1,116.03%447.8M
1,147.99%446.38M
873.62%340.78M
873.62%340.78M
--339.47M
--36.83M
--35.77M
5.71%35M
--35M
Gains losses not affecting retained earnings
--441K
---23K
153.85%7K
135.71%30K
135.71%30K
--0
--0
---13K
---84K
---84K
Total stockholders'equity
74.39%170.68M
192.38%183.29M
198.61%190.02M
148.71%91.07M
148.71%91.07M
--97.88M
---198.41M
---192.7M
-18.13%-186.95M
---186.95M
Total equity
74.39%170.68M
192.38%183.29M
198.61%190.02M
148.71%91.07M
148.71%91.07M
--97.88M
---198.41M
---192.7M
-18.13%-186.95M
---186.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 49.73%152.49M798.92%166.37M667.03%193.71M193.39%94.9M193.39%94.9M--101.84M--18.51M--25.25M-42.99%32.35M--32.35M
-Cash and cash equivalents -24.38%77.01M418.47%95.96M1,332.78%176.78M47,456.33%75.14M47,456.33%75.14M--101.84M--18.51M--12.34M-99.72%158K--158K
-Short-term investments --75.47M--70.41M31.06%16.93M-38.61%19.76M-38.61%19.76M--0--0--12.92M--32.19M--32.19M
Prepaid assets 379.04%4.3M143.14%248K79.37%678K227.36%1.35M227.36%1.35M--897K--102K--378K-2.36%413K--413K
Current deferred assets --306K--0--0--323K--323K------2.64M--1.33M--0--0
Other current assets 31.17%101K21.50%130K30.12%108K117.65%74K117.65%74K--77K--107K--83K-59.52%34K--34K
Total current assets 52.88%157.19M680.89%166.75M619.06%194.49M194.72%96.65M194.72%96.65M--102.82M--21.35M--27.05M-44.10%32.79M--32.79M
Non current assets
Net PPE 4.59%114K4.86%151K-79.21%37K-65.57%73K-65.57%73K--109K--144K--178K-38.01%212K--212K
-Gross PPE 4.59%114K4.86%151K-79.21%37K-65.57%73K-65.57%73K--109K--144K--178K-38.01%212K--212K
Investments and advances --17.47M--22.12M--------------------------------
Non current prepaid assets --------------0--0--0--0--27K0.00%27K--27K
Total non current assets 16,033.03%17.59M15,364.58%22.27M-81.95%37K-69.46%73K-69.46%73K--109K--144K--205K-35.23%239K--239K
Total assets 69.81%174.78M779.24%189.02M613.79%194.53M192.81%96.72M192.81%96.72M--102.93M--21.5M--27.25M-44.05%33.03M--33.03M
Liabilities
Current liabilities
Payables -32.31%1.15M-26.77%1.99M-63.66%531K-83.47%186K-83.47%186K--1.7M--2.72M--1.46M47.83%1.13M--1.13M
-accounts payable -32.31%1.15M-26.77%1.99M-63.66%531K-83.47%186K-83.47%186K--1.7M--2.72M--1.46M47.83%1.13M--1.13M
Current accrued expenses -10.67%2.81M53.86%3.57M12.24%3.95M30.42%5.17M30.42%5.17M--3.15M--2.32M--3.52M189.34%3.96M--3.96M
Current debt and capital lease obligation 12.62%116K9.29%153K-81.02%26K-51.13%65K-51.13%65K--103K--140K--137K7.26%133K--133K
-Current capital lease obligation 12.62%116K9.29%153K-81.02%26K-51.13%65K-51.13%65K--103K--140K--137K7.26%133K--133K
Other current liabilities -88.42%11K-90.29%10K----308.77%233K308.77%233K--95K--103K--167K-69.19%57K--57K
Current liabilities -18.95%4.09M8.34%5.73M-14.70%4.51M7.10%5.65M7.10%5.65M--5.05M--5.29M--5.29M116.35%5.28M--5.28M
Non current liabilities
Long term debt and capital lease obligation --------------0--0--0--0--39K-65.18%78K--78K
-Long term capital lease obligation --------------0--0--0--0--39K-65.18%78K--78K
Derivative product liabilities --------------0--0--1K----------4K--4K
Preferred securities outside stock equity --------------0--0--0--214.63M--214.63M-0.00%214.62M--214.62M
Total non current liabilities --0--0--0--0--0--1K--214.63M--214.67M-0.07%214.7M--214.7M
Total liabilities -18.97%4.09M-97.40%5.73M-97.95%4.51M-97.43%5.65M-97.43%5.65M--5.05M--219.91M--219.95M1.24%219.98M--219.98M
Shareholders'equity
Share capital 50.00%3K200.00%3K200.00%3K100.00%2K100.00%2K--2K--1K--1K0.00%1K--1K
-common stock 50.00%3K200.00%3K200.00%3K100.00%2K100.00%2K--2K--1K--1K0.00%1K--1K
-Preferred stock --0--0--0--0--0--0----------0--0
Retained earnings -15.53%-279.11M-12.43%-264.49M-12.22%-256.37M-12.56%-249.74M-12.56%-249.74M---241.59M---235.24M---228.46M-15.94%-221.87M---221.87M
Paid-in capital 32.37%449.35M1,116.03%447.8M1,147.99%446.38M873.62%340.78M873.62%340.78M--339.47M--36.83M--35.77M5.71%35M--35M
Gains losses not affecting retained earnings --441K---23K153.85%7K135.71%30K135.71%30K--0--0---13K---84K---84K
Total stockholders'equity 74.39%170.68M192.38%183.29M198.61%190.02M148.71%91.07M148.71%91.07M--97.88M---198.41M---192.7M-18.13%-186.95M---186.95M
Total equity 74.39%170.68M192.38%183.29M198.61%190.02M148.71%91.07M148.71%91.07M--97.88M---198.41M---192.7M-18.13%-186.95M---186.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data